AOX BIOPHARMA LLC – Trademark Portfolio

Entity Type: 16

AOX BIOPHARMA LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 2 are pending. Notable registered marks include LAVENGEL and A DOT ON THE SPOT. The owner is based in ST. CHARLES, IL.

3955 COMMERCE DR.

ST. CHARLES, IL 60174

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

AOX BIOPHARMA LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does AOX BIOPHARMA LLC have?

AOX BIOPHARMA LLC has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 pending, 1 abandoned.

What trademark classes does AOX BIOPHARMA LLC file in?

AOX BIOPHARMA LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are AOX BIOPHARMA LLC's most well-known trademarks?

AOX BIOPHARMA LLC's registered trademark portfolio includes well-known marks such as LAVENGEL and A DOT ON THE SPOT. These are among 2 currently registered trademarks in the portfolio.

What is AOX BIOPHARMA LLC's trademark registration success rate?

AOX BIOPHARMA LLC has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 2 applications are pending review.